Tag: NeuExcell

Using NeuExcell’s neuroregenerative gene therapy platform, the collaboration aims to develop an effective and safe treatment for patients suffering from Huntington’s Disease. Spark Therapeutic’s excellence in R&D and proprietary adeno-associated virus (AAV) vector gene therapy platform may advance the development […]

August 23, 2021. State College, Pennsylvania  – NeuExcell Therapeutics Inc. (www.neuexcell.com) today announced the appointment of Russ Addis, Ph.D. to the new position of Vice President, Research, effective immediately. Dr. Addis will report directly to Dr. Ronald HW Lorijn, Chief […]